Why support us?

Donating to the Centre Baclesse means giving hope to cancer patients.

Your donation, whatever the amount, can have a significant impact on patients' lives and help advance cancer research. We still need your help!

Your donations and legacies are absolutely essential to intensify research into all cancers, encourage innovation for the benefit of patients and improve their quality of life.

Without your trust, we wouldn't be able to carry out as many innovative projects, and progress would inevitably take longer.

THANKS TO YOU IN 2023

1- GENETICS

The Centre Baclesse is France's^leading laboratory for diagnosing genetic predispositions to breast and ovarian cancer.

The research teams have been able to work with and access this expertise thanks to thepurchase of a DNA sequencer made with your donations. They also analyze genetic predispositions to digestive and urological cancers. These research teams are continuing their efforts to gain a better understanding of human genes and tumor genomics.

2- IN BIOLOGY

Researchers from the ORGAPRED university platform laboratory create micro-tumors - "tumor organoids" - from cells derived from cancerous tumors harvested from patients. By exposing these micro-tumors to new therapies, we canidentify effective new molecules, and ultimately develop personalized medicine for each patient. By exposing these micro-tumors to a panel of existing treatments, we hope to find the one that will be most effective for the patient.

3- IN EPIDEMIOLOGY

The fight against cancer is based not only on therapeutic management, but also on identifying and reducing risk factors.

Generally speaking, it's not easy to distinguish between genetic, environmental and behavioral factors in the development of cancer. TheAGRICAN study, involving 180,000 people followed since 2005, was set up in mainland France to answer the question of the link between agricultural occupational exposure and the risk of cancer. Thanks to the work of researchers on this cohort, the world's largest cohort of farmers, prostate cancer was recognized in 2021 as an occupational disease among workers exposed to pesticides, thus entitling them to compensation.
These studies are also helping to implement protective and preventive measures to reduce exposure to the risk of cancer.

4- PROTON THERAPY

The Centre Baclesse is one of only 3 centers in France to offer this innovative radiotherapy technique.

The Centre Baclesse is involved in research into this cutting-edge radiotherapy, to treat rare or radiation-resistant tumors and better preserve the surrounding healthy tissue.

5- IN CLINICAL RESEARCH

The Centre Baclesse is the only center in Normandy to have been awarded the "CLIP2" label by the French National Cancer Institute, enabling it to conduct early-phase clinical trials, giving access to therapeutic innovation.

By 2022, more than 160 trials have been offered to patients, enabling them to benefit from new therapies, safely and as early as possible.